Successful use of gentamycin as an antibiotic prophylaxis regimen to reduce the rate of healthcare-associated infections after renal transplantation  by Abboud, Cely S. et al.
b r a z j i n f e c t d i s . 2 0 1 3;1 7(2):254–255
The Brazilian Journal of
INFECTIOUS  DISEASES
www. elsev ier .com/ locate /b j id
Brief communication
Successful  use  of  gentamycin  as  an antibiotic  prophylaxis
regimen to reduce  the  rate  of healthcare-associated
infections after  renal  transplantation
Cely S. Abboud ∗, Maria Daniela Bergamasco, Ercilia Evangelista de Sousa,
Eliana  de Cássia Zandonadi, Doralice Cortez
Instituto Dante Pazzanese de Cardiologia, São Paulo, Brazil
a  r  t  i  c  l  e  i  n  f  o
Article history:
Received 15 August 2012
Accepted  7 October 2012
Available  online 28 February 2013
Keywords:
Renal transplantation
Antibiotic prophylaxis
Gentamycin
Health-care associated infections
a  b  s  t  r  a  c  t
At our institution, we observed an increase in the incidence of healthcare-associated infec-
tions (HAI) due to Gram-negative bacilli, including three cases of carbapenem-resistant
Klebsiella pneumoniae, among patients who underwent renal transplantation. In addition
to  strengthening infection control measures, we chose to add gentamycin to the antibiotic
prophylaxis  regimen of patients undergoing renal transplantation. We  assessed the number
of  HAI occurring within 30 days of renal transplantation during two time periods: (1) the pre-
intervention  period, between September 2009 and June 2010, and (2) the post-intervention
period,  between July 2010 and April 2011. The intervention consisted of the addition of gen-
tamycin  to the surgical antibiotic prophylaxis regimen. The percentage of patients with
HAIs  was 31% lower during the post-intervention period (p = 0.03), with the greatest reduc-
tions  observed for urinary tract infections (p = 0.024). Carbapenem-resistant K. pneumoniae
was  not isolated during this period. The investigated patients did not exhibit worseningrenal  function. Further studies are needed to assess antibiotic prophylaxis in renal trans-
plantation  patients at institutions where there is a high prevalence of multidrug-resistant
Gram-negative bacteria.
350  beds for cardiovascular surgeries. Approximately 40 renal
transplantation surgeries are performed annually. The Institu-
© 2013 Elsevier Editora Ltda. Este é um artigo Open Access sob a licença de CC BY-NC-NDThe optimal perioperative antibiotic prophylaxis regimen for
renal transplant patients remains to be determined, and pro-
phylaxis  should be administered based exclusively on clinical
evidence.1,2
At our institution, the Infection Control team observed an
increase  in the incidence of healthcare-associated infections
(HAI)  due to Gram-negative bacilli, including three cases of
carbapenem-resistant Klebsiella pneumoniae, among patients
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Este é um artigo Open Access sob a licençawho underwent renal transplantation,3,4 and measures were
proposed  to reduce the incidence of HAI.
The Instituto Dante Pazzanese de Cardiologia, located in
São  Paulo, is a public university hospital with a capacity of Dr. Dante Pazzanese, 500, São Paulo, SP 04012-909, Brazil.
tion  has a hospital infection control and prevention program
and  performs active disease surveillance, following criteria
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Table 1 – Clinical characteristics of the patients during
the  pre- and post intervention periods.
Characteristics of
patients
Pre-
intervention
period
Post-
intervention
period
p*
N renal TX 24 21
Average age 46.4 47.5 NS
DM 2 16.7% (4/24) 23.8% (5/21) NS
Deceased donor 87.5% (21/24) 90.5% (19/21) NS
Median length of
surgery
300  min (5 h) 270 min (4 h 30)
Double J 70.8%  (17/24) 71.4%  (15/21) NS
Median use of drain 13 days 10 days
Median of use IC 10 days 8 days
Death within 30 days 8.3% (2/24) 4.8% (1/21) NS
HAI rates within 30 days 54.2%  (13/24) 19%  (4/12) 0.03
Surgical site infection
(SSI)
16/7%  (4/24) 9.5% (2/21) 0.66
Urinary tract infection
(UTI)
33.3%  (8/24) 4.85 (1/21) 0.024
Primary bloodstream
infection
4.2%  (1/24) 0
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∗ p value-Fischer exact test.
rom the Centers for Disease Control and Prevention (CDC).5
We  assessed the number of HAI occurring within 30 days
f  renal transplantation during two time periods: (1) the pre-
ntervention  period, between September 2009 and June 2010,
nd  (2) the post-intervention period, between July 2010 and
pril  2011.
The  intervention consisted of an addition of gentamycin to
he  surgical antibiotic prophylaxis regimen. This addition was
ased  on the previously determined sensitivity proﬁle of HAI-
ausing  bacteria. Antibiotic prophylaxis was  administered
uring the post-intervention period. This regimen included
wo  doses of gentamycin 2 mg/kg, one at the start of anesthe-
ia  and one 24 h later; one dose of cefuroxime 1.5 g at the start
f  anesthesia; and 750 mg  of cefuroxime every 12 h for the next
8  h. Cefuroxime had been previously used at our institution.
The characteristics of the patients during the pre- and post-
ntervention periods are presented in Table 1.
The microorganisms isolated during the pre-intervention
eriod were,  4 Enterobacter spp., 4 Escherichia coli, 1 Proteus
irabilis, 1 multi-sensitive K. pneumoniae and 3 carbapenem-
esistant K. pneumonia. In the post-intervention period 1
nterobacter  cloacae, 1 E. coli and 1 multi-sensitive K. pneumoniae
ere  isolated.
The  percentage of patients with HAIs was 31% lower dur-
ng  the post-intervention period (p = 0.03), with the greatest
eductions observed for urinary tract infections (p = 0.024).
arbapenem-resistant K. pneumoniae was  not isolated during
his  period.
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The  investigated patients did not exhibit worsening renal
function.
The  optimal regimen for perioperative antibiotic prophy-
laxis  after renal transplantation remains to be determined. At
our institution, we observed an increase in HAI in renal trans-
plantation  patients and, in addition to strengthening infection
control  measures we  were  encouraged to add gentamycin
to  the antibiotic prophylaxis regimen of patients undergoing
renal  transplantation. In the post-intervention period a signiﬁ-
cant  reduction in HAI was observed (p = 0.03), with the greatest
reductions observed for urinary tract infections (p = 0.024).
Based on these ﬁndings, gentamycin was included in the
institutional protocol for surgical antibiotic prophylaxis for
renal  transplantation.
A  limitation of this study is that only one public hospital
in  São Paulo was  evaluated, such that the sample may  not
represent  the general Brazilian population.
Further studies are needed to assess antibiotic prophy-
laxis in renal transplantation patients. These studies should
include  a larger number of patients and should be conducted
at  institutions where there is a high prevalence of multidrug-
resistant Gram-negative bacteria.
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